- Research works
- 60 ▼ 11% vs 2013–17
- Citations
- 1.9k 31.4 per fractional work
- Top-10% rate
- 17.0% record average 16.5%
- Open access
- 65% world 28%
Not ranked overall: AC Immune (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 5.8×. Every wedge is a field page.
- Neuroscience 5.8×
- Immunology and Microbiology 4.6×
- Medicine 3.0×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Economics, Econometrics and Finance 1.2×
- Pharmacology, Toxicology and Pharmaceutics 1.1×
- Mathematics 1.1×
- Arts and Humanities 0.7×
- Computer Science 0.6×
- Social Sciences 0.2×
- Physics and Astronomy 0.1×
- Chemistry 0.1×
Which keywords describe research at AC Immune (Switzerland)?
By fractional works in all years, weighted toward what it does more of than the world: Neurodegeneration, Oxidative Stress, Neuroinflammation, Amyloid Hypothesis, Tau Pathology, Alzheimer's Disease, Neurodegenerative Diseases and Pharmacology.
- Synaptic Pruning
- a-Synuclein
- Neurotransmission
- Ischemic Stroke
- GABAergic
- Cytokines
- Crystal Structure
- Protein Aggregation
- Virtual Screening
- Monoclonal Antibodies
- Drug Target Identification
- Mitochondrial Dysfunction
- Molecular Docking
- Parkinson's Disease
- Cholinesterase Inhibitors
- Drug Development
- Pharmacology
- Alzheimer's Disease
- Amyloid Hypothesis
- Oxidative Stress
- Neurodegeneration
- Neuroinflammation
- Tau Pathology
- Neurodegenerative Diseases
- Toxicology
- Acetylcholinesterase
- Neurological Disorders
- Innate Immunity
- Machine Learning
- Pharmacokinetics
- Glycosylation
- Therapeutic Antibodies
- Diagnostic Criteria
- Antibody Engineering
- Fc Receptors
- Dopaminergic Neurons
- Genetic Risk Factors
- Microglia
- Synaptic Plasticity
- Astrocytes
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Neurodegeneration16▲ 87×6 topics
- Oxidative Stress13▲ 12×8 topics
- Neuroinflammation13▲ 77×6 topics
- Amyloid Hypothesis10▲ 320×1 topic
- Tau Pathology10▲ 320×1 topic
- Alzheimer's Disease7▲ 40×7 topics
- Neurodegenerative Diseases6▲ 47×6 topics
- Pharmacology6▲ 29×3 topics
- Toxicology5▲ 38×2 topics
- Drug Development5▲ 53×2 topics
- Acetylcholinesterase4▲ 253×1 topic
- Cholinesterase Inhibitors4▲ 253×1 topic
- Neurological Disorders4▲ 10×6 topics
- Parkinson's Disease4▲ 28×4 topics
- Innate Immunity3▲ 16×5 topics
- Molecular Docking3▲ 39×2 topics
- Machine Learning3▲ 2.5×3 topics
- Mitochondrial Dysfunction3▲ 14×5 topics
- Pharmacokinetics3▲ 18×2 topics
- Drug Target Identification3▲ 71×1 topic
- Glycosylation3▲ 22×3 topics
- Monoclonal Antibodies3▲ 35×2 topics
- Therapeutic Antibodies3▲ 39×2 topics
- Virtual Screening3▲ 71×1 topic
- Diagnostic Criteria2▲ 20×2 topics
- Protein Aggregation2▲ 49×3 topics
- Antibody Engineering2▲ 36×1 topic
- Crystal Structure2▲ 15×3 topics
- Fc Receptors2▲ 36×1 topic
- Cytokines2▲ 13×2 topics
- Dopaminergic Neurons2▲ 55×2 topics
- GABAergic2▲ 26×1 topic
- Genetic Risk Factors2▲ 70×1 topic
- Ischemic Stroke2▲ 25×2 topics
- Microglia2▲ 40×2 topics
- Neurotransmission2▲ 26×1 topic
- Synaptic Plasticity2▲ 11×2 topics
- a-Synuclein2▲ 70×1 topic
- Astrocytes2▲ 73×1 topic
- Synaptic Pruning2▲ 73×1 topic
Which research topics does AC Immune (Switzerland) publish most on?
By volume in 2022–2025: Alzheimer's disease research and treatments, Amyotrophic Lateral Sclerosis Research, Parkinson's Disease Mechanisms and Treatments and Cholinesterase and Neurodegenerative Diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Alzheimer's disease research and treatments Physiology 2 works
- 2 Amyotrophic Lateral Sclerosis Research Neurology 2 works
- 3 Parkinson's Disease Mechanisms and Treatments Neurology 1 works
- 4 Cholinesterase and Neurodegenerative Diseases Pharmacology 1 works
- 5 Neuroinflammation and Neurodegeneration Mechanisms Neurology 1 works
- 6 Cancer-related cognitive impairment studies Pulmonary and Respiratory Medicine 0 works
- 7 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
- 8 Neurological disorders and treatments Neurology 0 works
- 9 Cancer Treatment and Pharmacology Oncology 0 works
- 10 Prion Diseases and Protein Misfolding Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AC Immune (Switzerland)'s research output changed?
Output in 2018–2022 was 11% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lausanne
- École Polytechnique Fédérale de Lausanne
- University of Lausanne
- University Hospital of Lausanne
- Hôpital Orthopédique de la Suisse Romande
- Institute of Social and Preventive Medicine
- SIB Swiss Institute of Bioinformatics
- Département de la Santé et de l'Action Sociale
- Hôpital Nestlé
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.